Patents by Inventor Lars Damstrup

Lars Damstrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER
    Publication number: 20230272083
    Abstract: The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises an anti-PD-L antibody and a DNA-PK inhibitor, optionally together with one or more additional chemotherapeutic agents or radiotherapy. The therapeutic combination is particularly intended for use in treating a subject having a cancer that tests positive for PD-L1 expression.
    Type: Application
    Filed: December 23, 2022
    Publication date: August 31, 2023
    Inventors: Astrid ZIMMERMANN, Lars DAMSTRUP, Anne-Kathrin PROKEIN, Andreas SCHROEDER
  • Combination of a protein kinase inhibitor and an additional chemotherapeutic agent
    Patent number: 11246929
    Abstract: Combination therapy for the treatment of cancer.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: February 15, 2022
    Assignee: MERCK PATENT GMBH
    Inventors: Lars Damstrup, Thomas Grombacher, Christian Sirrenberg, Lyubomir Vassilev, Astrid Zimmermann
  • COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER
    Publication number: 20200048352
    Abstract: The present invention relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to a therapeutic combination which comprises an anti-PD-L antibody and a DNA-PK inhibitor, optionally together with one or more additional chemotherapeutic agents or radiotherapy. The therapeutic combination is particularly intended for use in treating a subject having a cancer that tests positive for PD-L1 expression.
    Type: Application
    Filed: March 27, 2018
    Publication date: February 13, 2020
    Inventors: Astrid Zimmermann, Lars Damstrup, Anne-Kathrin Prokein, Andreas Schroeder
  • COMBINATION OF A PROTEIN KINASE INHIBITOR AND AN ADDITIONAL CHEMOTHERAPEUTIC AGENT
    Publication number: 20190365896
    Abstract: Combination therapy for the treatment of cancer.
    Type: Application
    Filed: December 18, 2017
    Publication date: December 5, 2019
    Inventors: Lars Damstrup, Thomas Grombacher, Christian Sirrenberg, Lyubomir Vassilev, Astrid Zimmermann